A trio of drugmakers are treading the boards to raise awareness of global antimicrobial resistance (AMR). Pfizer, GSK and Shionogi have all signed on to sponsor the upcoming London run of the stage ...
The truth is that cancer has touched or will touch most people’s lives in some way; one in three people in the U.S. are expected to receive a cancer diagnosis in their lifetime.[1] And alarmingly, ...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. modRNA shingles pursuit from Pfizer and BioNTech now centers on the terminated Phase 1/2 study formally titled “A PHASE 1/2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results